Kinetic and Structural Characterization of Trypanosoma cruzi Hypoxanthine–Guanine–Xanthine Phosphoribosyltransferases and Repurposing of Transition-State …
K Glockzin, KM Meneely, R Hughes, SW Maatouk… - Biochemistry, 2023 - ACS Publications
Over 70 million people are currently at risk of developing Chagas Disease (CD) infection,
with more than 8 million people already infected worldwide. Current treatments are limited …
with more than 8 million people already infected worldwide. Current treatments are limited …
[HTML][HTML] Clinicopathological alterations in wild mammals from the reservoir system of Trypanosoma cruzi: a scoping review
R Sánchez Pérez, JM Aranda-Coello… - Animal Diseases, 2024 - Springer
Trypanosoma cruzi is the etiologic agent of Chagas disease. This flagellated protozoan is
transmitted to humans as well as different species of domestic and wild animals via vectors …
transmitted to humans as well as different species of domestic and wild animals via vectors …
[HTML][HTML] Chronic Chagas Cardiomyopathy in the Brazilian Amazon region: clinical characteristics and regional distinctiveness
EI Guevara Moctezuma, S Smith Doria… - Frontiers in Public …, 2023 - frontiersin.org
Objectives This study aims to provide a comprehensive analysis of clinical and
epidemiological data related to Chronic Chagas Cardiomyopathy (CCC) in the Amazon …
epidemiological data related to Chronic Chagas Cardiomyopathy (CCC) in the Amazon …
寄生原虫嘌呤磷酸核糖转移酶研究进展.
余志会， 方肆云， 孙铭飞， 戚南山… - Guangdong …, 2023 - search.ebscohost.com
寄生原虫是一类单细胞寄生性原虫, 包括利什曼原虫(Leishmania spp.), 锥虫(Trypanosoma
spp.), 疟原虫(Plasmodium spp.), 刚地弓形虫(Toxoplasma gondii), 隐孢子虫(Cryptosporidium …
spp.), 疟原虫(Plasmodium spp.), 刚地弓形虫(Toxoplasma gondii), 隐孢子虫(Cryptosporidium …